EPSRC fund UK biopharmaceutical sector research

EPSRC to fund UK biopharmaceutical sector research

12:05 PM, 6th November 2012
EPSRC to fund UK biopharmaceutical sector research

SWINDON, UK: The EPSRC Centre for Innovative Manufacturing in Emergent Macromolecular Therapies is offering funding to academics outside the centre for up to 10 research feasibility studies related to the manufacture of biopharmaceuticals.

The research is to establish a centre that delivers innovation in manufacturing research to assess emergent challenges facing the UK biopharmaceutical sector, and which impact its global competitiveness. The EPSRC Centre will act as the focus for a national network of leading users and academics in manufacturing and provide strong support for UK industry.

It aims to be recognized as the primary centre for the creation, delivery and dissemination of decision-support tools to enable the manufacture and lifecycle optimization of novel macromolecular therapies. This will widen access to valuable therapies for patient by decreasing development timelines, raising manufacturing efficiency and reduce costs to the purchaser (eg NHS).

Studies will be funded in four themes aligned to the programme of the EPSRC Centre. The feasibility studies should examine the subject area in the field, identify key challenges and research questions not currently being addressed and develop full proposals for funding by established routes.

It is expected that studies will develop preliminary data and or demonstrate experimental methodologies as well as undertaking the necessary desk research. Feasibility studies are expected to lead to significant new funding involving the centre and attracting industrial support. Awards are limited to a maximum of £20,000 at 80 per cent FEC and for a project duration of 6 to 12 months. Recipients must be from institutions outside the centre and be eligible to hold an EPSRC grant.

The centre employs 8 PDRAs across the remit of its programme. These PDRAs are part of the centre resources that can be made available to these feasibility studies.

© WOC News

 

0 Comments

Login

Your Comments (Up to 2000 characters)
Please respect our community and the integrity of its participants. WOC reserves the right to moderate and approve your comment.

Related News


BASF to build largest European emissions catalysts plant in Poland

LUDWIGSHAFEN, GERMANY: BASF is investing approximately €90 million to build a mobile emissions catalysts production facility in Sroda Slaska (Spe ...

Read more
Clariant to unveil innovative Hostavin NOW technology for agriculture films

MUTTENZ, SWITZERLAND: Clariant, supports a step-forward in effective crop protection with launch of innovative stabilization solutions to improve dura ...

Read more
Sapphire, Institute for Systems Biology to develop algae biofuels

SAN DIEGO, US: Sapphire Energy and Institute for Systems Biology (ISB) formed a strategic partnership to further scientific research and development o ...

Read more
Oxea plans downstream plant expansion feasibility study

OBERHAUSEN, GERMANY: The chemical company Oxea is in the last stages of completion of a feasibility study of additional downstream plant expansion pro ...

Read more
Dow opens photovoltaics application lab in Shanghai, China

MIDLAND, US: The Dow Chemical Company has opened a photovoltaics films application laboratory in Shanghai, China to help customers in the Asia-Pacific ...

Read more
Momentive, UPC JV for phenolic resins in China

COLUMBUS, US: Momentive Specialty Chemicals and UPC Technology Corporation have recently broken ground on a joint venture manufacturing facility. The ...

Read more